학술논문

Phase I/II tolerability/pharmacokinetic study with one-hour intravenous infusion of doxifluiridine (5'-dFUrd) 3 g/m2 VS 5 g/m2 QD x 5 per month.
Document Type
journal article
Source
Cancer Chemotherapy & Pharmacology; Dec1986, Vol. 18 Issue 3, p252-256, 5p
Subject
ADENOCARCINOMA
ANTINEOPLASTIC agents
CLINICAL trials
COLON tumors
COMPARATIVE studies
DRUG tolerance
CLINICAL drug trials
INTRAVENOUS therapy
RESEARCH methodology
MEDICAL cooperation
RECTUM tumors
RESEARCH
STATISTICAL sampling
TIME
EVALUATION research
RANDOMIZED controlled trials
CECUM
FLUORODEOXYURIDINE
TUMORS
Language
ISSN
03445704
Abstract
Copyright of Cancer Chemotherapy & Pharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)